CME Group Inc. (CME)
CME Group (CME) Is Up 1.44% in One Week: What You Should Know
Does CME Group (CME) have what it takes to be a top stock pick for momentum investors? Let's find out.
CME Group: Expect Generous Dividends This Year
CME Group thrives on market volatility, earning revenue on every trade, making it resilient in both good and bad times. CME's niche in the derivatives market, international expansion, and product innovation drive growth, especially during uncertain times. Strong financials, including solid profit margins and high dividend payouts, make CME an attractive investment for income-focused investors.
CME: More Market Volatility Equals More Demands - Initiating With Strong Buy
Initiating a 'Strong Buy' rating for CME with a fair value of $301 per share due to increased demand for hedging amid economic uncertainty and market volatility. CME's diverse product offerings and strong trading volume growth, particularly in interest rate options/futures, equity, FX, energy, and commodities, support its robust business model. CME's high operating margin, capex-light business model, and strategic use of Google Cloud enhance profitability and operational efficiency.
3 Stocks to Buy Before the May 7 Catalyst
Tom Yeung here with your Sunday Digest. In the 1990s, my father moved our family to a new overseas “Florida-style” housing development.
CME Q1 Earnings Beat Estimates on Higher Trading Volume, Revenues Lag
CME Group's Q1 results reflect improved revenues and increased volatility that aided volumes.
CME Group Inc. Q1 2025 Earnings Call Transcript
CME Group Inc. Q1 2025 Earnings Conference Call April 23, 2025 8:30 AM ET Company Participants Adam Minick - Investor Relations Terry Duffy - Chairman & Chief Executive Officer Suzanne Sprague - Chief Operating Officer & Head, Risk and Clearing Sunil Cutinho - Chief Information Officer Lynne Fitzpatrick - Chief Financial Officer Derek Sammann - Global Head, Commodities Julie Winkler - Chief Commercial Officer Mike Dennis - Global Head, Fixed Income Conference Call Participants Kyle Voigt - KBW Dan Fannon - Jefferies Patrick Moley - Piper Sandler Ken Worthington - JP Morgan Ben Budish - Barclays Capital Bill Katz - TD Cowen Owen Lau - Oppenheimer Alex Kramm - UBS Craig Siegenthaler - Bank of America Brian Bedell - Deutsche Bank Alex Blostein - Goldman Sachs Ashish Sabadra - RBC Capital Markets Chris Allen - Citi Simon Clinch - Redburn Atlantic Operator Welcome to the CME Group First Quarter 2025 Earnings Call. At this time, I would like to inform all participants that your lines have been placed on a listen-only mode until the question-and-answer session of today's conference.
CME (CME) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
The headline numbers for CME (CME) give insight into how the company performed in the quarter ended March 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
CME Group (CME) Q1 Earnings Top Estimates
CME Group (CME) came out with quarterly earnings of $2.80 per share, beating the Zacks Consensus Estimate of $2.79 per share. This compares to earnings of $2.50 per share a year ago.
Will Trading Volume Aid CME Group to Deliver Q1 Earnings Beat?
CME's first-quarter performance is likely to have benefited from a diverse product portfolio, increased volatility and a strong market position.
Curious about CME (CME) Q1 Performance? Explore Wall Street Estimates for Key Metrics
Besides Wall Street's top -and-bottom-line estimates for CME (CME), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended March 2025.
If I Retired Today, These 3 Dividend Stocks Would Be My Paycheck
The 60/40 portfolio used to be a rock-solid strategy. But persistent inflation and bond market volatility have turned the "safe" 40% into a real risk. I'm not a fan of bonds—and with good reason. I'd rather own high-quality businesses with dependable dividends and stronger long-term return potential. In this article, I highlight three stable, income-focused stocks I'd buy without hesitation to reduce portfolio risk and potentially outperform the 60/40 crowd.
CME Group (CME) Earnings Expected to Grow: Should You Buy?
CME (CME) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
